A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 2: cobalamin C deficiency.

Irini ManoliJennifer G MylesJennifer L SloanNuria Carrillo-CarrascoEva MoravaKevin A StraussHolmes MortonCharles P Venditti

Published in: Genetics in medicine : official journal of the American College of Medical Genetics (2015)

Patients with cblC deficiency treated with medical foods designed for isolated methylmalonic acidemia are at risk for iatrogenic methionine deficiency that could adversely affect brain growth and development.Genet Med 18 4, 396-404.

Keyphrases

healthcare
replacement therapy
primary care
white matter
resting state
multiple sclerosis
brain injury
smoking cessation
blood brain barrier